TransMedics Group (TMDX)
(Delayed Data from NSDQ)
$119.15 USD
+4.86 (4.25%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $118.87 -0.28 (-0.23%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TMDX 119.15 +4.86(4.25%)
Will TMDX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TMDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TMDX
Why TransMedics (TMDX) is a Top Growth Stock for the Long-Term
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is TransMedics (TMDX) Down 1.9% Since Last Earnings Report?
Here's Why TransMedics (TMDX) is a Strong Momentum Stock
Here's Why TransMedics (TMDX) is a Strong Growth Stock
Other News for TMDX
TransMedics Group (TMDX): Evercore ISI Initiates Coverage with 'Outperform' Rating | TMDX Stock News
Apple initiated, Hershey upgraded: Wall Street’s top analyst calls
Apple initiated, Hershey upgraded: Wall Street's top analyst calls
TransMedics Group (TMDX) Has a New Rating from Roth MKM
Crossed Above 20 Day Moving Average appears for TMDX after 0.24% move